{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:22:25Z","timestamp":1791598945322,"version":"4.3.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:p>The societal burden of ischemic stroke suggests a need for additional therapeutic categories in stroke prevention. Modulation of the endocannabinoid system (ECS) is a rational target for stroke prevention because of its effects on inflammation, vascular tone, and metabolic balance, all well-described stroke risk factors. In this article, we summarize the existing ECS clinical studies in human subjects' research as they relate to conventional vascular risk factors associated with ischemic stroke. To date, 2-arachidonoylglycerol (2-AG) derivative endocannabinoids are consistently reported to be elevated in insulin resistance, whereas the N-arachidonoylethanolamine (AEA) endocannabinoid derivatives are elevated in obesity. The ECS role in metabolic health should examine the effects of 2-AG reduction and AEA augmentation as a means of stroke risk reduction. Cannabinoid receptors are reported on macrophages within atherosclerotic plaques and suggest a role for immunomodulation as a therapeutic for atherosclerosis through both peripheral immune cell CB1 antagonism and\/or CB2 agonist. The effects of ECS on hypertension, smoking, physical activity, obstructive sleep apnea, heart failure, and atrial fibrillation are incompletely described and deserve further study. A limitation to ECS research is significant overlap with noncannabinoid molecular targets. Further exploration of the ECS needs to include the larger metabolomics context for a greater understanding of its therapeutic potential. Clinical translational studies in stroke prevention should be directed at ECS in metabolic balance and atherosclerosis.<\/jats:p>","DOI":"10.1089\/can.2018.0066","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T11:02:58Z","timestamp":1556276578000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Endocannabinoids and Stroke Prevention: Review of Clinical Studies"],"prefix":"10.1177","volume":"5","author":[{"given":"Eugene L.","family":"Scharf","sequence":"first","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon O.","family":"Ebbert","sequence":"additional","affiliation":[{"name":"Community Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.115"},{"key":"e_1_3_2_3_2","first-page":"246","article-title":"Calcitonin gene related peptide level and endocannabinoid system activity in patients with abdominal obesity and arterial hypertension","volume":"22","author":"Shlyakhto E","year":"2012","unstructured":"Shlyakhto E, , Bazhenova E, , Belyaeva O. Calcitonin gene related peptide level and endocannabinoid system activity in patients with abdominal obesity and arterial hypertension. Clin Auton Res. 2012; 22:246\u2013247.","journal-title":"Clin Auton Res"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-11-32"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.100"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-8-7"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104534"},{"key":"e_1_3_2_8_2","first-page":"10S","article-title":"Endocannabinoid plasma levels are independent predictors of coronary endothelial dysfunction in obesity","volume":"20","author":"Quercioli A","year":"2011","unstructured":"Quercioli A, , Pataky Z, , Vincenti G, et al. Endocannabinoid plasma levels are independent predictors of coronary endothelial dysfunction in obesity. Kardiovask Med. 2011; 20:10S\u201311S.","journal-title":"Kardiovask Med"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142728"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803539"},{"key":"e_1_3_2_11_2","first-page":"211","article-title":"Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women","volume":"22","author":"Abdulnour J","year":"2014","unstructured":"Abdulnour J, , Yasari S, , Rabasa-Lhoret R, et al. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study. Obesity. 2014; 22:211\u2013216.","journal-title":"A MONET group study. Obesity"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-9-43"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0643"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347440"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.03.027"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0812"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2001.01942.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00790.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3455"},{"key":"e_1_3_2_20_2","first-page":"9782031","article-title":"Circulating endocannabinoids and insulin resistance in patients with obstructive sleep apnea","volume":"2016","author":"Wang X","year":"2016","unstructured":"Wang X, , Yu Q, , Yue H, et al. Circulating endocannabinoids and insulin resistance in patients with obstructive sleep apnea. Biomed Res Int. 2016; 2016:9782031.","journal-title":"Biomed Res Int"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283591595"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-011-2237-0"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-012-2495-5"},{"key":"e_1_3_2_24_2","first-page":"A489","article-title":"Intense resistance exercise does not alter circulating endo cannabinoids despite significant elevations in growth hormone in type 1 diabetes individuals","volume":"63","author":"Turner D","year":"2014","unstructured":"Turner D, et al. Intense resistance exercise does not alter circulating endo cannabinoids despite significant elevations in growth hormone in type 1 diabetes individuals. Diabetes. 2014; 63:A489.","journal-title":"Diabetes"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2011.09.017"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2009.10.025"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2011.06.159"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.811992"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr449"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2009.00679.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0650"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2018.0066","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2018.0066","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2018.0066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:10:54Z","timestamp":1777385454000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2018.0066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3,1]]}},"alternative-id":["10.1089\/can.2018.0066"],"URL":"https:\/\/doi.org\/10.1089\/can.2018.0066","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]}}}